Sysmex Inostics specializes in purpose-designed ultra-high sensitivity tests capable of detecting genetic alterations at very low mutant allele frequencies.
Through reliable identification of even the lowest frequency mutations, our OncoBEAM™ and SafeSEQ testing services help ensure the most efficient approach to patient enrollment in clinical trials for targeted therapies.
Our technologies are also ideal to explore novel clinical applications which require ultra-high sensitivity, such as molecular monitoring of minimal residual disease.
